The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: The PLATON Network
Official Title: The Platform for Analyzing Targetable Tumor Mutations Network (Main-study)
Study ID: NCT05489250
Brief Summary: The PLATON Network study is designed to elevate personalized therapy based on genomic tumor profiles in gastrointestinal cancer patients. Hereby, PLATON's study-design focuses on the patient's tumor molecular profiling. Within the network a web application will be developed to link clinical investigators and information on study sites, cancer patients and genetic alteration data, as well as available clinical trials at PLATON's study sites.
Detailed Description: The PLATON Network is established as permanent open, multicenter, prospective, cohort study of patients with gastrointestinal cancer. The study design includes a study-specific biobank and a shared platform infrastructure for associated sub-studies and analysis projects. Within PLATON results of genetic tests of different research projects like the PLATON pilot-study (NCT04484636) as well as Next-generation deep sequencing (NGS) according to local protocols will be documented - compiling genomic tumor-profiles including tumor mutational burden (TMB) and microsatellite instability (MSI). The PLATON Network infrastructure is designed to increase the likelihood of treating the patients with an individualized therapy in available clinical studies. Therefore, molecular profiling must go hand in hand with inter-linking physicians and increasing inter-centre transparency. The feasibility of this approach will be tested in the PLATON Network, keeping in mind the vision of cancer patients receiving the best available, scientifically founded, biomarker-based care, tailored to his or her individual needs.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
KHNW Frankfurt, Frankfurt, Hessen, Germany
Friedrich-Ebert-Krankenhaus Neumünster, Neumünster, Schleswig-Holstein, Germany
HELIOS Klinikum Bad Saarow, Bad Saarow, , Germany
Evangelisches Waldkrankenhaus Spandau, Berlin, , Germany
MVZ Oskar-Helene-Heim Berlin, Berlin, , Germany
Augusta-Kranken-Anstalt Bochum, Bochum, , Germany
Bochum Uni, Bochum, , Germany
Klinikum Chemnitz, Chemnitz, , Germany
GEFOS - Gesellschaft für onkologische Studien Dortmund, Dortmund, , Germany
Onkozentrum Dresden, Dresden, , Germany
Ev. Kliniken Essen-Mitte, Klinik für Internistische Onkologie, Essen, , Germany
MVZ Onkologische Kooperation Harz, Goslar, , Germany
Universitätsklinikum Halle (Saale), Halle, , Germany
Hamburg Onkologische Schwerpunktpraxis Eppendorf, Hamburg, , Germany
St. Anna Hospital Herne, Herne, , Germany
Ortenau Klinikum Lahr-Ettenheim, Lahr, , Germany
ÜBAG - MVZ Dr. Vehling-Kaiser GmbH, Landshut, , Germany
Langen, Gemeinschaftspraxis für Hämatologie und Onkologie, Langen, , Germany
Studienzentrum UnterEms, Leer, , Germany
Klinikum Lippe, Lemgo, , Germany
Klinikum Ludwigsburg, Ludwigsburg, , Germany
Klinik München-Bogenhausen, München, , Germany
Münster, Gemeinschaftspraxis für Hämatologie und Onkologie, Münster, , Germany
Medius Klinik Osterfildern-Ruit, Ostfildern, , Germany
Krankenhaus Barmherzige Brüder, Regensburg, , Germany
Klinikum Rheine, Mathias-Spital Rheine, Rheine, , Germany
CaritasKlinikum Saarbrücken, Saarbrücken, , Germany
Onkologie Bodensee, Singen, , Germany
Marien Hospital Witten, Witten, , Germany
Klinikum Wolfsburg, Wolfsburg, , Germany
Onkologisches Zentrum Wolfsburg-Helmstedt MVZ GmbH, Wolfsburg, , Germany
Name: Salah-Eddin Al-Batran, Prof. Dr.
Affiliation: Institut für Klinische Krebsforschung IKF GmbH am Krankenhaus Nordwest
Role: STUDY_DIRECTOR
Name: Arndt Vogel, Prof. Dr.
Affiliation: Hannover Medical School (MHH)
Role: PRINCIPAL_INVESTIGATOR